A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2007
10/24/2007	CN100344970C Treatment and diagnosis of cancer
10/24/2007	CN100344329C Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
10/24/2007	CN100344327C Vaccine for reticuloendothliosis of poultry and preparing method thereof
10/23/2007	US7285654 Stimulus-inducible protein kinase complex and methods of use therefor
10/23/2007	US7285650 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
10/23/2007	US7285644 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007	US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007	US7285639 Antibody to telomerase reverse transcriptase
10/23/2007	US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007	US7285624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007	US7285539 Using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides and polynucleotides encoding them
10/23/2007	US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007	US7285532 Therapeutic method for treating bone formation diseases
10/23/2007	US7285527 Tumor radiosensitization using gene therapy
10/23/2007	US7285524 Allo and auto-reactive T-cell epitopes
10/23/2007	US7285398 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders
10/23/2007	US7285397 Gene expressing wasp poison allergen antigen 5 in bacteria in an insoluble form as inclusion bodies; denaturing using guanidine chloride without any reducing agent, and dialysis against acidic buffer; immunotherapy; genetic engineering
10/23/2007	US7285391 Using human chorionic gonadotrophin specific monoclonal antibody to prognose/diagnose gestational trophoblast disease; tumor diagnosis
10/23/2007	US7285382 Compositions and methods for treatment of cancer
10/23/2007	US7285289 Nanoparticle vaccines
10/23/2007	US7285282 Mucin peptide with immunoenhancing properties
10/23/2007	US7285281 Genetically engineered toxin comprising a-subunit of wildtype cholera toxin for treatment and prevention of infections, cell proliferative, nervous system and metabolic disorders
10/23/2007	US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007	US7285278 Method and device for detecting feline immunodeficiency virus
10/23/2007	US7285277 Administering LK6/68 proteins in which sequence is identical to apolipoprotein kringle domains to reduce tumor growth; recombinant Escherichia; for treatment of cancer, rheumatoid arthritis, and psoriasis
10/23/2007	US7285276 Polynucleotide sequence for Chlamydia pneumonia; therapy, prevention of Chlamydia infections
10/23/2007	US7285274 Baculovirus produced Plasmodium falciparum vaccine
10/23/2007	US7285273 Administering an immunogenically effective amount of TH epitope-containing IL5 polypeptide wherein TH epitope-containing IL5 polypeptide differs from the animal's autologous IL5 polypeptide in that the TH epitope-containing IL5 polypeptide comprises at least one foreign TH epitope
10/23/2007	US7285272 Method and device for detecting feline immunodeficiency virus
10/23/2007	US7285271 Antigenic composition comprising an HIV gag or env polypeptide
10/23/2007	US7285270 Administering to the patient an effective amount of antibody monocyte chemoattractant protein-1 (MCP-1) antibody or binding fragment thereof thereby reducing neuropathic pain characterized by an increase in MCP-1 levels
10/23/2007	US7285269 Monoclonal antibody for use in diagnosis, prevention and treatment of infection, autoimmune, skin, cell proliferative and inflammatory disorders
10/23/2007	US7285267 Antiinflammatory agents
10/23/2007	CA2341946C Polypetides and compositions prepared from the amplification of the hiv-2 and siv-type retrovirus genome,
10/23/2007	CA2263889C P-selectin ligand proteins
10/23/2007	CA2206179C Vectors for tissue-specific replication
10/23/2007	CA2142981C Vaccines against group c neisseria meningitidis
10/23/2007	CA2111325C Detection of mammalian immunodeficiency viruses
10/23/2007	CA2086258C Pasteurella multocida toxoid vaccines
10/18/2007	WO2007118214A2 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007	WO2007118206A2 Canine influenza virus
10/18/2007	WO2007118084A2 Compositions and methods for treating polycystic kidney disease
10/18/2007	WO2007117996A2 Methods for treating conditions associated with masp-2 dependent complement activation
10/18/2007	WO2007117964A2 Apparatus and method for vaccine development using ultrasound technology
10/18/2007	WO2007117763A2 Methods and compositions for targeting relt
10/18/2007	WO2007117749A2 Il-17 antagonistic antibodies fpr treating cancer
10/18/2007	WO2007117686A2 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/18/2007	WO2007117685A2 Conjugates of an anti-tnf-alpha antibody
10/18/2007	WO2007117680A2 Methods and compositions for treating bacterial infection
10/18/2007	WO2007117600A2 Combination therapy for treating autoimmune diseases
10/18/2007	WO2007117599A2 A method for measuring the content of a botulinum toxin in a formulation
10/18/2007	WO2007117596A1 Compositions and methods for the analysis and treatment of aids wasting syndrome and immune cell dysfunction
10/18/2007	WO2007117577A2 High affinity human antibodies to human il-18 receptor
10/18/2007	WO2007117505A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/18/2007	WO2007117371A2 Engineered listeria and methods of use thereof
10/18/2007	WO2007117356A2 Immunoglobulins from vitiligo plasma for melanoma therapy
10/18/2007	WO2007117339A2 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
10/18/2007	WO2007117303A2 Combination vaccine comprising an attenuated bovine viral diarrhea virus
10/18/2007	WO2007117038A1 Prophylactic/therapeutic agent for cancer
10/18/2007	WO2007116962A1 Muscle regeneration promoter
10/18/2007	WO2007116945A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007	WO2007116409A2 Improved vaccines comprising multimeric hsp60 peptide carriers
10/18/2007	WO2007116316A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
10/18/2007	WO2007116032A1 Vaccine against mycoplasma prrsv
10/18/2007	WO2007116028A2 Conjugate vaccines
10/18/2007	WO2007115837A2 Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule
10/18/2007	WO2007115829A2 Anti ku70 internalizing antibodies
10/18/2007	WO2007115813A1 Glycosylated antibodies
10/18/2007	WO2007115713A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
10/18/2007	WO2007087384A3 Methods for modulating mannose content of recombinant proteins
10/18/2007	WO2007077464A3 Chicken virus vaccine and diagnostic
10/18/2007	WO2007059715A3 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
10/18/2007	WO2007052155A3 Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
10/18/2007	WO2007050102A3 Dendritic cell based vaccines
10/18/2007	WO2007034166A8 Adjuvanted vaccine
10/18/2007	WO2007033167A3 Compositions and methods for detecting and treating cancer
10/18/2007	WO2007028117A3 P8 as a marker for heart failure
10/18/2007	WO2007011265A8 Method for blocking noggin2 target specific activities
10/18/2007	WO2006041933A3 Improved vaccines
10/18/2007	WO2005103303A3 Apparatus and method for transdermal delivery of multiple vaccines
10/18/2007	WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007	WO2002010354A3 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2)
10/18/2007	WO2001030974A3 Molecules targeting cd40 which do not activate cd40-expressing cells
10/18/2007	US20070244303 comprising an Fc region derived from a human IgG heavy chain, wherein the Fc region lacks effector function; for the reduction of a deleterious immune response; idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia
10/18/2007	US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt
10/18/2007	US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007	US20070244047 Albumin fusion proteins
10/18/2007	US20070243632 Methods for measuring platelet reactivity of patients that have received drug eluting stents
10/18/2007	US20070243580 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/18/2007	US20070243524 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
10/18/2007	US20070243260 Treatment of Childhood Asthma
10/18/2007	US20070243215 Adjuvant for Dna Vaccines
10/18/2007	US20070243214 Genes and proteins associated with angiogenesis and uses thereof
10/18/2007	US20070243213 Hbv Variants Detection and Application
10/18/2007	US20070243212 Methods and compositions for vaccination of poultry
10/18/2007	US20070243209 Compositions and methods for prevention and treatment of fungal diseases
10/18/2007	US20070243208 Novel chimeric protein for prevention and treatment of hiv infection
10/18/2007	US20070243207 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
10/18/2007	US20070243206 Using hybrid fibrin peptides to prevent hemophilus infection
10/18/2007	US20070243205 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus

1 ... 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 ... 1823